Moolec Science SA
MLECdata completeness 88%3 fiscal years on fileData notes: no data for concept 'totalDebt'; no data for concept 'interestExpense'
Moolec Science SA earns about -563% on invested capital, but has diluted owners by 2% over 3 years — worth asking whether the growth reaches owners. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|
| Revenue | — | $905,0491 | $5.63M1 |
| Net income | −$4.53M2 | −$51.8M2 | −$7.31M2 |
| Operating cash flow | −$1.89M3 | −$7.51M3 | −$9.33M3 |
| Capital expenditure | — | $14,8244 | $158,2834 |
| Free cash flow (derived) | — | −$7.53M3 | −$9.49M3 |
| Total debt | — | — | — |
| Cash & equivalents | $1.08M5 | $2.53M6 | $5.39M6 |
| Diluted shares | — | 37.6M | 38.4M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $1.77 of net worth that earned you −$1.9 and generated −$2.47 of cash last year.
It earned an average -563% on invested capital over 3 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is up 2% over 3 years — owners have been diluted. Worth asking what they got for it.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 20-F · period ending 2023-06-30 · accession 0001213900-24-092168 (Revenue)
- 20-F · period ending 2022-06-30 · accession 0001213900-24-092168 (ProfitLoss)
- 20-F · period ending 2022-06-30 · accession 0001213900-24-092168 (CashFlowsFromUsedInOperatingActivities)
- 20-F · period ending 2023-06-30 · accession 0001213900-24-092168 (PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities)
- 20-F/A · period ending 2022-06-30 · accession 0001213900-23-082664 (CashAndCashEquivalents)
- 20-F · period ending 2023-06-30 · accession 0001213900-24-092168 (CashAndCashEquivalents)